Login / Signup
Ying Song
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Smoking Cessation
Endometrial Cancer
Health Insurance
Radiation Therapy
Top Venues
Translational lung cancer research
Journal of gynecologic oncology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Gengwei Huo
,
Ying Song
,
Xiongwen Chen
,
Peng Chen
Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis.
Translational lung cancer research
13 (4) (2024)
Gengwei Huo
,
Ying Song
,
Xiongwen Chen
,
Peng Chen
Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis.
Translational lung cancer research
13 (4) (2024)
Gengwei Huo
,
Ying Song
,
Peng Chen
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.
Journal of gynecologic oncology
(2024)
Gengwei Huo
,
Ying Song
,
Peng Chen
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer.
Journal of gynecologic oncology
(2024)